Drug watch.
- Published in:
- 2006
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2006 AND VI 41 AND IP 6
Results: 21
1
2
Drug and formulary trends.
- Published in:
- 2006
- Publication type:
- Journal Article
3
News capsules. New monoclonal antibody effective for plaque psoriasis.
- Published in:
- 2006
- Publication type:
- Journal Article
4
ACE inhibitors versus ARBs: comparison of practice guidelines and treatment selection considerations.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
5
FDA drug approvals. FDA actions in brief.
- Published in:
- 2006
- Publication type:
- Journal Article
6
Focus on... Varenicline: an oral partial nicotine agonist for smoking cessation.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
7
Drug Watch.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 296
- Publication type:
- Article
8
Deal limitations, promotion of generic medications aim to stem rising drug costs, but threaten access.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 295
- By:
- Publication type:
- Article
9
Planning for a paradigm shift in the realm of over-the-counter medications.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 290
- By:
- Publication type:
- Article
10
Drug and Formulary Trends.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 289
- Publication type:
- Article
11
Lower oral retinoid dose effective for psoriasis.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 288
- Publication type:
- Article
12
New monoclonal antibody effective for plaque psoriasis.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 287
- Publication type:
- Article
13
Entecavir demonstrates higher rates of improvement than lamivudine in patients with hepatitis B.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 287
- Publication type:
- Article
14
Tiotropium use in patients with COPD exacerbation improves airflow limitation and decreases health resource utilization.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 285
- Publication type:
- Article
15
Conflict of interest disclosures common at FDA advisory meetings, rarely result in recusals.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 285
- Publication type:
- Article
16
ACE inhibitors versus ARBs: comparison of practice guidelines and treatment selection considerations.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 274
- By:
- Publication type:
- Article
17
Meta-analysis of anti-TNF agents in RA treatment trials suggests increased risk of infection, malignancies.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 273
- Publication type:
- Article
18
Varenicline.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 265
- By:
- Publication type:
- Article
19
FDA actions in brief.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 264
- Publication type:
- Article
20
New molecular entities.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 262
- Publication type:
- Article
21
Pipeline preview.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 262
- Publication type:
- Article